-
Something wrong with this record ?
NFKB1 Signalling Activation Contributes to TRPV1 Over-expression via Repressing MiR-375 and MiR-455: a Study on Neuropathic Low Back Pain
Z. Li, Y. Zhou, Z. Li
Language English Country Czech Republic
Document type Journal Article
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- TRPV Cation Channels genetics metabolism MeSH
- Humans MeSH
- Low Back Pain * MeSH
- RNA, Messenger MeSH
- MicroRNAs * metabolism MeSH
- NF-kappa B p50 Subunit genetics metabolism MeSH
- Signal Transduction MeSH
- Up-Regulation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Transient receptor potential cation channel subfamily V member 1 (TRPV1) has been found over-expressed in low back pain (LBP) patients with neuropathic pain (NP), but the underlying mechanism is still unclear. In the present study, the up-regulation of the TRPV1 protein level in sinuvertebral nerve biopsies from patients with NP was verified by immunoblotting, but the TRPV1 mRNA level was not significantly changed. MiRNAs targeting TRPV1 mRNA were predicted by a bioinformatic tool, and the interactions between the miRNAs and TRPV1 were confirmed by dual luciferase assay. The correlation between NFKB1 signalling and TRPV1 expression was analysed and confirmed by using sNF96.2 cells after lipopolysaccharide stimulation. We found that five out of 18 miRNAs repressed TRPV1 expression, and the levels of miR-375 and miR-455 were negatively correlated with the protein level of TRPV1 in patients with NP. MiR-375 and miR-455 were identified to repress TRPV1 expression via targeting the 3'UTR of TRPV1 mRNA. NFKB1 signalling activation down-regulated the expression of miR-375 and miR-455, and thus up-regulated the TRPV1 protein level. In conclusion, we partially unveiled the mechanism of how TRPV1 is over-expressed in chronic LBP patients with NP and provided two potential candidate miRNAs for NP treatment.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22033985
- 003
- CZ-PrNML
- 005
- 20230213133248.0
- 007
- ta
- 008
- 230207s2022 xr da f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)36689317
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Li, Z. $u Department of Orthopaedics and Plastic Surgery, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan 430050, Hubei Province, China
- 245 10
- $a NFKB1 Signalling Activation Contributes to TRPV1 Over-expression via Repressing MiR-375 and MiR-455: a Study on Neuropathic Low Back Pain / $c Z. Li, Y. Zhou, Z. Li
- 520 9_
- $a Transient receptor potential cation channel subfamily V member 1 (TRPV1) has been found over-expressed in low back pain (LBP) patients with neuropathic pain (NP), but the underlying mechanism is still unclear. In the present study, the up-regulation of the TRPV1 protein level in sinuvertebral nerve biopsies from patients with NP was verified by immunoblotting, but the TRPV1 mRNA level was not significantly changed. MiRNAs targeting TRPV1 mRNA were predicted by a bioinformatic tool, and the interactions between the miRNAs and TRPV1 were confirmed by dual luciferase assay. The correlation between NFKB1 signalling and TRPV1 expression was analysed and confirmed by using sNF96.2 cells after lipopolysaccharide stimulation. We found that five out of 18 miRNAs repressed TRPV1 expression, and the levels of miR-375 and miR-455 were negatively correlated with the protein level of TRPV1 in patients with NP. MiR-375 and miR-455 were identified to repress TRPV1 expression via targeting the 3'UTR of TRPV1 mRNA. NFKB1 signalling activation down-regulated the expression of miR-375 and miR-455, and thus up-regulated the TRPV1 protein level. In conclusion, we partially unveiled the mechanism of how TRPV1 is over-expressed in chronic LBP patients with NP and provided two potential candidate miRNAs for NP treatment.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a lumbalgie $7 D017116
- 650 12
- $a mikro RNA $x metabolismus $7 D035683
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a upregulace $7 D015854
- 650 _2
- $a messenger RNA $7 D012333
- 650 _2
- $a kationtové kanály TRPV $x genetika $x metabolismus $7 D050916
- 650 _2
- $a NF-kappa B - podjednotka p50 $x genetika $x metabolismus $7 D052002
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zhou, Y. $u Department of Orthopaedics, Xiantao First People's Hospital Affiliated to Yangtzeu University, Xiantao 430050, Hubei Province, China
- 700 1_
- $a Li, Z. $u Department of Orthopaedics, Taikang Tongji (Wuhan) Hospital, Wuhan 430050, Hubei Province, China
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 68, č. 3 (2022), s. 105-111
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36689317 $y Pubmed
- 856 41
- $u https://fb.cuni.cz/file/6221/fb2022a0013.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y p $z 0
- 990 __
- $a 20230207 $b ABA008
- 991 __
- $a 20230213133245 $b ABA008
- 999 __
- $a ok $b bmc $g 1897229 $s 1185374
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 68 $c 3 $d 105-111 $e - $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK138 $a Pubmed-20230207